Cable Viewer

Currently released so far... 12478 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AU ASEC AE AF AORC AEMR AMGT ABUD AFFAIRS APER AS AMED AY AG AR AJ AL AID AM AODE ABLD AMG AFIN ATRN AGAO AFU AN AA ALOW APECO ADM ARF ASEAN APEC AMBASSADOR AO ASUP AZ AADP ACOA ANET AMCHAMS ACABQ ASECKFRDCVISKIRFPHUMSMIGEG APCS AGMT AINF AIT AORL ACS AFSI AFSN ACBAQ AFGHANISTAN ADANA ADPM AX ADCO AECL AMEX ACAO ASCH AORG AGR AROC ASIG AND ARM AQ ATFN AC AUC ASEX AER AVERY AGRICULTURE
BL BR BO BA BD BM BK BG BU BB BH BTIO BY BEXP BP BE BRUSSELS BF BIDEN BT BX BC BILAT BN BBSR BTIU BWC BMGT
CA CASC CVIS CM CH CO CU CD CWC CI CS CY CMGT CF CG CR CB CV CW CE CBW CT CPAS COUNTERTERRORISM CJAN CODEL CIDA CDG CDC CIA CTR CNARC CSW CN CONS CLINTON COE CROS CARICOM CONDOLEEZZA COUNTER CL COM CICTE CIS CFED COUNTRY CJUS CBSA CEUDA CLMT CAC COPUOS CIC CBE CHR CTM CVR CITEL CLEARANCE CACS CAN CITT CARSON CACM CDB CAPC CKGR CBC
DEAX DR DJ DA DEA DOMESTIC DO DK DHS DAO DCM DTRA DISENGAGEMENT DOD DPRK DEPT DOE DS DE DEFENSE
EC EG EPET ECON ETRD EFIN EIND EMIN ENRG EAID EAGR EUN ETTC EAIR ENIV ES EU EINV ELAB ECIN EFIS ELTN EWWT ECPS ECONOMIC ENGR EN EINT EPA ELN ESA EZ ER ET EFTA EINVECONSENVCSJA EUMEM ETRA EXTERNAL EI EUR EK ERNG ENGY ETRDEINVECINPGOVCS ENERG EINVEFIN ENVR ECA ELECTIONS ETC EUREM ENNP EFINECONCS EURN ECINECONCS EEPET EXIM ERD ENVI ETRC ETRDEINVTINTCS ETRO EDU ETRN EAIG ECONCS ECONOMICS EAP ECONOMY EINN EIAR EXBS ECUN EINDETRD EREL EUC ESENV ECONEFIN ECIP EFIM EAIDS ETRDECONWTOCS EUNCH EINVETC
FR FI FJ FBI FAC FM FO FAO FDA FTAA FARC FTA FREEDOM FISO FOR FOREIGN FOI FAS FINR FINANCE FMLN
GM GG GE GT GR GH GTIP GV GA GOI GAERC GY GOV GERARD GANGS GAZA GTMO GL GF GCC GZ GLOBAL
HA HO HU HUMOR HK HURI HR HEBRON HSTC HILLARY HUMAN HI HYMPSK
IZ IT IR IS IN IC IAEA IO ICAO IWC ID IV ISRAEL IAHRC IQ ICTR IMF IRS IDP IGAD ICRC ICTY IMO IL INRA INRO ICJ ITU IBRD INMARSAT IIP ITALY IEFIN IACI ILO INTELSAT ILC ITRA IDA INRB IRC INTERPOL IA IPR IRAQI ISRAELI INTERNAL ISLAMISTS INDO ITPHUM ITPGOV ITALIAN IBET INR IEA IZPREL IRAJ ITF IF
JO JA JM JOHN JP JOSEPH JUS JAMES JOHNNIE
KDEM KU KPAL KNNP KCRM KZ KN KS KJUS KTFN KSCA KV KISL KPAO KPKO KIRF KTIA KIPR KFLO KFRD KTIP KAWC KSUM KCOM KAID KE KTDB KMDR KOMC KWBG KDRG KVPR KTEX KGIC KWMN KSCI KCOR KACT KDDG KHLS KSAF KFLU KSEO KMRS KSPR KOLY KSEP KVIR KGHG KIRC KUNR KIFR KCIP KMCA KMPI KBCT KHSA KICC KIDE KCRS KMFO KRVC KRGY KR KAWK KG KFIN KHIV KBIO KOCI KBTR KNEI KPOA KCFE KPLS KSTC KHDP KPRP KCRCM KLIG KCFC KTER KREC KTBT KPRV KSTH KRIM KRAD KWAC KWMM KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KOMS KX KMIG KRCM KVRP KBTS KPAONZ KNUC KNAR KPWR KNPP KDEMAF KNUP KNNPMNUC KERG KGIT KPAI KTLA KFSC KCSY KSAC KTRD KID KOM KMOC KJUST KGCC KREL KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFTFN KO KNSD KHUM KSEC KCMR KCHG KICA KPIN KESS KDEV KCGC KWWMN KPAK KWNM KWMNCS KRFD
LY LH LG LE LO LI LA LU LTTE LAB LOG LT LABOR
MOPS MCAP MPOS MARR MO MNUC MX MASS MG MY MU ML MR MILITARY MTCRE MT MEPP MA MDC MP MAR MASSMNUC MARAD MAPP MZ MD MI MEETINGS MK MCC MEPN MRCRE MAS MIL MASC MC MV MTCR MIK MUCN MEDIA MERCOSUR MW MOPPS MTS MLS MILI MTRE MEPI MQADHAFI MAPS
NO NATO NL NP NZ NSF NI NH NG NAFTA NU NASA NR NATOPREL NSSP NSG NA NT NW NK NPT NPA NATIONAL NPG NSFO NS NSC NE NGO NDP NIPP NRR NEW NZUS NC NAR NV NORAD
OTRA OPCW OVIP OAS OREP OPIC OIIP OPRC ODIP OEXC OPDC OSCE OIC OSCI OECD OFDP OFDA OMIG OPAD OFFICIALS OVP OIE OHUM OCS OBSP OTR OSAC ON OCII OES
PGOV PREL PHUM PTER PINS PINR PREF PK PROP PA PARM PBTS PMAR PM PGIV PE PRAM PHUH PHSA PL PNAT PO PLN PAO PSA PHUMPGOV PF PEL PBIO POLITICS PHUMBA PAS POL PREO PAHO PMIL POGOV POV PAK PNR PRL PG PREFA PSI PINL PU PARMS PRGOV PALESTINIAN PAIGH POLITICAL PARTIES POSTS PROG PORG PTBS PUNE POLICY PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PP PS PY PTERE PGOF PKFK PSOE PEPR PPA PINT PRELP PSEPC PGOVE PINF PNG PGOC PFOR PCUL POLINT PGGV PHALANAGE PARTY PGOVLO PHUS PDEM PECON PROV PHUMPREL
QA
RS RU RELATIONS RW RO RM RP ROOD RICE RUPREL RSO RCMP REACTION REPORT REGION RIGHTS RF RFE RSP RIGHTSPOLMIL ROBERT
SU SCUL SNAR SOCI SF SA SHUM SENV SP SR SY SANC SC SMIG SZ SARS SW SEVN SO SEN SL SNARCS SNARN SI SG SN SH SYR SAARC SPCE SHI SCRS SENVKGHG SYRIA SWE STEINBERG SIPRS ST SNARIZ SSA SK SPCVIS SOFA SIPDIS SAN
TC TI TBIO TH TSPL TRGY TSPA TPHY TU TW TS TAGS TK TX TNGD TZ TF TL TV TN TD TIP TR TP TO TT TFIN THPY TERRORISM TINT TRSY TURKEY TBID
US UK UNGA UP UZ UNMIK USTR UNO UNSC UN UNESCO UNAUS UNHRC UY UG UNHCR UNCND USOAS USEU UNICEF UNEP UV UNPUOS UNCSD USUN UNCHR UNDC USNC UE UNDP UNC USPS USAID UNVIE UAE UNFICYP UNODC UNCHS UNIDROIT UNDESCO UNCHC
VE VT VZ VTIZ VTPREL VAT VC VM VN VTEG VI
WHO WTRO WS WZ WHA WI WMD WHTI WA WTO WMO WBG WITH WIPO WTRQ WFP WWARD WB WEU
XR XM XL XS XW XF XG XT XU XA XK XY XV XB XZ XQ XC XTAG XX XE XD XH XI
YM YI YE YMCS
ZB ZU ZP ZR ZI ZANU ZL ZF ZJ ZO ZEALAND ZK ZN ZA ZOELLICK

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`